Identified: Levels of antibody protection required to prevent symptomatic COVID-19
Researchers from the University of Oxford have today released their findings about the so-called ‘correlates of protection’ against symptomatic COVID-19; […]
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are […] Researchers at Children's Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in […] The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a respiratory virus with […] The heterogeneous coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in Wuhan, […] A team of scientists in Israel recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2 (also […] New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus […] The body's immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the […] Researchers in the United States and Canada have conducted a study showing that just a single dose of either the […] Britain has been home to many pioneers of immunology, ranging from cellular biologists to virologists and biochemists. This article aims […]antibody
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines
CHOP researchers identify key target responsible for treatment failure in patients with hemophilia A
Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents
Living with a COVID-19 case brings worse symptoms and stronger antibody response
Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response
New COVID-19 variants can evade antibodies that work against original form of the virus
SARS-CoV-2 can evade immune response by T-killer cells through mutations
Both mRNA vaccines protect against emerging variants of SARS-CoV-2
Immunology: A Very British History